XML 20 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Changes in Shareholders' Equity
$ in Thousands
USD ($)
shares
Issued and Outstanding Shares
USD ($)
shares
Additional paid-in capital
USD ($)
Accumulated other comprehensive income (loss)
USD ($)
Accumulated deficit
USD ($)
Number of shares outstanding at beginning of period (in shares) at Mar. 31, 2021 | shares   128,528,515      
Number of shares issued at the beginning of period (in shares) at Mar. 31, 2021 | shares   128,528,515      
Equity at beginning of period at Mar. 31, 2021 $ 1,934,283 $ 2,526,448 $ 35,877 $ 9,715 $ (637,757)
Net loss (288,433)       (288,433)
Increase (decrease) in number of ordinary shares issued (in shares) | shares   8,855,000      
Issuance of shares upon public offerings 823,515 $ 823,515      
Share issuance costs $ (33,984) $ (33,984)      
Number of share options exercised in share-based payment arrangement (in shares) | shares 1,061,359 1,332,218      
Exercise of stock options and settlement of share awards $ 17,494 $ 38,510 (21,016)    
Share-based compensation 108,916   108,916    
Share-based acquisition-related compensation (in shares) | shares   638,323      
Share-based acquisition-related compensation 45,042 $ 45,042      
Shares issued in connection with business combination (in shares) | shares   9,307,256      
Shares issued in connection with business combination 799,494 $ 799,494      
Other comprehensive loss $ (7,038)     (7,038)  
Number of shares outstanding at end of period (in shares) at Mar. 31, 2022 | shares   148,661,312      
Number of shares issued at the end of period (in shares) at Mar. 31, 2022 | shares 148,661,312 148,661,312      
Equity at end of the period at Mar. 31, 2022 $ 3,399,289 $ 4,199,025 123,777 2,677 (926,190)
Net loss (1,070,009)       (1,070,009)
Share issuance costs $ (193) $ (193)      
Number of share options exercised in share-based payment arrangement (in shares) | shares 942,641 2,224,787      
Exercise of stock options and settlement of share awards $ 4,710 $ 59,632 (54,922)    
Share-based compensation 129,167   129,167    
Share-based acquisition-related compensation (in shares) | shares   284,206      
Share-based acquisition-related compensation 40,219 $ 40,219      
Other comprehensive loss $ (5,734)     (5,734)  
Number of shares outstanding at end of period (in shares) at Mar. 31, 2023 | shares   151,170,305      
Number of shares issued at the end of period (in shares) at Mar. 31, 2023 | shares 151,170,305 151,170,305      
Equity at end of the period at Mar. 31, 2023 $ 2,497,449 $ 4,298,683 $ 198,022 $ (3,057) $ (1,996,199)